Results 131 to 140 of about 1,264,995 (315)

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

CHILD SURVIVAL AND CHILD DEVELOPMENT IN DEVELOPING COUNTRIES [PDF]

Journal of Paediatrics and Child Health, 2011
openaire   +2 more sources

Interpreting the effects of DNA polymerase variants at the structural level

Molecular Oncology, EarlyView.
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi, Karolina Krzesińska, Ludovica Beltrame, Pablo Sánchez‐Izquierdo Besora, Matteo Tiberti, Mef Nilbert, Anna Rohlin, Elena Papaleo   +7 more
wiley   +1 more source

The Child Development Center gets a visit from the Carnegie Science Center

, 2020
WIS sponsors several visits from the Carnegie Science Center to the children at the Duquesne University Child Development Center. The first visit of Spring 2020 the pre-schoolers learned about gears and played with robots!https://dsc.duq.edu/wis-outreach-
Child Development Center, Duquesne University
core  

National Child Development Study: Teaching Sets, 1958-1981

, 1988
copyright UK Data Service and data collection copyright owner.The National Child Development Study (NCDS) is a continuing longitudinal study that seeks to follow the lives of all those living in Great Britain who were born in one particular ...
Jones, G., University of London, Institute of Education, Thomas Coram Research Unit, Manor, O., City University, Social Statistics Research Unit, Shepherd, P., City University, NCDS User Support Group   +2 more
core   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

Molecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura, Tadahiro Kuribayashi, Johannes Brägelmann, Sachi Okawa, Masataka Taoka, Shunta Mori, Tomoka Nishimura, Takaaki Tanaka, Go Makimoto, Kiichiro Ninomiya, Kammei Rai, Eiki Ichihara, Ryohei Katayama, Katsuyuki Hotta, Masahiro Tabata, Yosuke Togashi, Yoshinobu Maeda, Martin L. Sos, Katsuyuki Kiura, Kadoaki Ohashi   +19 more
wiley   +1 more source

Loss of IGF‐1R impairs DNA‐PKcs recruitment to chromatin leading to defective end‐joining

Molecular Oncology, EarlyView.
IGF‐1R promotes radioresistance by facilitating DNA‐PKcs recruitment to chromatin, enabling non‐homologous end‐joining (NHEJ) repair of double‐strand breaks. Inhibition or loss of IGF‐1R disrupts this recruitment to damage sites, driving compensatory reliance on microhomology‐mediated end‐joining (MMEJ) repair.
Matthew O. Ellis, Jack V. Mills, Wojciech Niedzwiedz, Valentine M. Macaulay   +3 more
wiley   +1 more source

Long-term efficacy and safety of topical therapy in pediatric moderate to severe atopic dermatitis (ROAD study)

Allergology International
Background: Data on the long-term efficacy and safety of topical therapy for atopic dermatitis (AD) remain limited. Methods: This prospective cohort study included all children with AD who had their first visit to the Allergy Center at the National ...
Tomoki Yaguchi, Kenji Toyokuni, Chisato Jimbo, Kouhei Hagino, Daisuke Harama, Marei Omori, Daichi Suzuki, Kotaro Umezawa, Mami Shimada, Hisako Ogasawara, Seiko Hirai, Fumi Ishikawa, Sayaka Hamaguchi, Ai Kishino, Mayako Saito-Abe, Miori Sato, Hideaki Morita, Ichiro Nomura, Tatsuki Fukuie, Yukihiro Ohya, Kiwako Yamamoto-Hanada   +20 more
doaj   +1 more source

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source

Safer oral immunotherapy with very low-dose introduction for pediatric hen’s egg allergy

Journal of Allergy and Clinical Immunology: Global
Background: Adverse events could be a barrier to implementing oral immunotherapy (OIT) in children with hen’s egg (HE) allergy, highlighting the need for safer OIT methods.
Fumi Ishikawa, MD, Yumiko Miyaji, MD, PhD, Kiwako Yamamoto-Hanada, MD, PhD, Mami Shimada, MD, Tomoyuki Kiguchi, MD, Seiko Hirai, MD, Yuri Endo Kram, MD, Kazuma Takada, MD, Kyoko Noguchi, MD, Yusuke Inuzuka, MD, Kenji Toyokuni, MD, PhD, Mayako Saito-Abe, MD, PhD, Miori Sato, MD, Shigenori Kabashima, MD, PhD, Kyongsun Pak, PhD, Eisuke Inoue, PhD, Tatsuki Fukuie, MD, PhD, Yukihiro Ohya, MD, PhD   +17 more
doaj   +1 more source